NASDAQ: OPRXOptimizerx Corp Stock
$4.54-0.14 (-2.99%)
Updated Jun 23, 2026
OPRX Price
$4.54
Fair Value Price
$5.62
Market Cap
$85.19M
52 Week Low
$4.54
52 Week High
$22.25
P/E
12.61x
P/B
0.66x
P/S
1.1x
PEG
0.1x
Dividend Yield
N/A
Revenue
$107.35M
Earnings
$6.84M
Gross Margin
70%
Operating Margin
13.73%
Profit Margin
6.4%
Debt to Equity
0.29
Operating Cash Flow
$14M
Beta
1.53
Next Earnings
Aug 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A
OPRX Overview
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OPRX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
OPRX
Ranked#4 of 44
Ranked#4 of 44
Be the first to know about important OPRX news, forecast changes, insider trades & much more!
OPRX News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OPRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OPRX ($4.54) is undervalued by 19.24% relative to our estimate of its Fair Value price of $5.62 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OPRX ($4.54) is not significantly undervalued (19.24%) relative to our estimate of its Fair Value price of $5.62 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OPRX ($4.54) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OPRX due diligence checks available for Premium users.
Valuation
OPRX fair value
Fair Value of OPRX stock based on Discounted Cash Flow (DCF)
Price
$4.54
Fair Value
$5.62
Undervalued by
19.24%
OPRX ($4.54) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OPRX ($4.54) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OPRX ($4.54) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OPRX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.61x
Industry
14.47x
Market
7.68x
OPRX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OPRX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
OPRX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.66x
Industry
3.07x
OPRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OPRX price to earnings growth (PEG)
For valuing profitable companies with growth potential
OPRX is good value based... subscribe to Premium to read more.
PEG Value Valuation
OPRX's financial health
Profit margin
Revenue
$19.8M
Net Income
-$495.0k
Profit Margin
-2.5%
OPRX's Earnings (EBIT) of $14.74M... subscribe to Premium to read more.
Interest Coverage Financials
OPRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$167.3M
Liabilities
$37.7M
Debt to equity
0.29
OPRX's short-term assets ($56.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPRX's short-term assets ($56.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
OPRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$467.0k
Investing
-$21.0k
Financing
-$2.7M
OPRX's operating cash flow ($14.38M)... subscribe to Premium to read more.
Debt Coverage Financials
OPRX vs Health Information Service Stocks
Optimizerx Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.